276 related articles for article (PubMed ID: 17625380)
1. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
2. [Computerized tomography and MR tomography in diagnosis of ovarian tumors].
Hamm B
Radiologe; 1994 Jul; 34(7):362-9. PubMed ID: 7938483
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
[TBL] [Abstract][Full Text] [Related]
4. [The diagnosis of computed tomography (CT) and magnetic resonance imaging (MRI) in evaluation of the extension of ovarian carcinoma].
Mizuno K
Rinsho Byori; 1992 Feb; 40(2):152-5. PubMed ID: 1583787
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of whole-body MRI and
Bruckmann NM; Sawicki LM; Kirchner J; Martin O; Umutlu L; Herrmann K; Fendler W; Bittner AK; Hoffmann O; Mohrmann S; Dietzel F; Ingenwerth M; Schaarschmidt BM; Li Y; Kowall B; Stang A; Antoch G; Buchbender C
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2816-2825. PubMed ID: 32333068
[TBL] [Abstract][Full Text] [Related]
6. Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody.
Juweid M; Sharkey RM; Alavi A; Swayne LC; Herskovic T; Hanley D; Rubin AD; Pereira M; Goldenberg DM
J Nucl Med; 1997 Feb; 38(2):257-60. PubMed ID: 9025751
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the results of preoperative studies with imaging procedures with the surgical status of ovarian cancer].
Simon WE; Lenz M; Storz A; Straussinsky G; Hirsch HA
Geburtshilfe Frauenheilkd; 1989 Jun; 49(6):568-72. PubMed ID: 2663620
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive monitoring of ovarian cancer: improved results using CT with intraperitoneal contrast combined with immunocytology.
Giunta S; Venturo I; Mottolese M; Salzano M; Diotallevi F; Squillaci S; Bigotti A; Curcio CG; Atlante G; Natali PG
Gynecol Oncol; 1994 Apr; 53(1):103-8. PubMed ID: 8175007
[TBL] [Abstract][Full Text] [Related]
9. [The place of radioimmunoscintigraphy in the diagnosis and follow-up of ovarian cancer in comparison with computed tomography and second-look surgery].
Barzen G; Friedmann W; Richter W; Schönegg W; Riess H; Eichstädt H; Lichtenegger W; Felix R
Nuklearmedizin; 1992 Feb; 31(1):16-23. PubMed ID: 1561116
[TBL] [Abstract][Full Text] [Related]
10. Whole-body [18F]FDG PET in the management of metastatic brain tumours.
Kim DG; Kim CY; Paek SH; Lee DS; Chung JK; Jung HW; Cho BK
Acta Neurochir (Wien); 1998; 140(7):665-73; discussion 673-4. PubMed ID: 9781280
[TBL] [Abstract][Full Text] [Related]
11. Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding.
Fanti S; Nanni C; Castellucci P; Farsad M; Rampin L; Gross MD; Mariani G; Rubello D
Cancer Imaging; 2006 Mar; 6(1):20-3. PubMed ID: 16581520
[TBL] [Abstract][Full Text] [Related]
12. Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
Braun C; Grünig H; Peikert J; Strobel K; Christmann-Schmid C; Brambs C
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():13-19. PubMed ID: 38394714
[TBL] [Abstract][Full Text] [Related]
13. Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.
Park SB; Park JM; Moon SH; Cho YS; Sun JM; Kim BT; Lee KH
PLoS One; 2018; 13(5):e0196808. PubMed ID: 29746513
[TBL] [Abstract][Full Text] [Related]
14. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).
Hubner KF; McDonald TW; Niethammer JG; Smith GT; Gould HR; Buonocore E
Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294
[TBL] [Abstract][Full Text] [Related]
15. [18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results].
Zimny M; Schröder W; Wolters S; Cremerius U; Rath W; Büll U
Nuklearmedizin; 1997 Oct; 36(7):228-33. PubMed ID: 9441281
[TBL] [Abstract][Full Text] [Related]
16. [Ultrasonic diagnosis of ovarian carcinoma].
Herrmann U; Dreher E; Goldhirsch A; Locher GW; Jann FX
Schweiz Med Wochenschr; 1983 Oct; 113(42):1544-9. PubMed ID: 6227990
[TBL] [Abstract][Full Text] [Related]
17. Real-time ultrasonography--an efficient screening method for abdominal and pelvic lymphadenopathy.
Beyer D; Peters PE
Lymphology; 1980 Sep; 13(3):142-9. PubMed ID: 7442307
[TBL] [Abstract][Full Text] [Related]
18. The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [
Sadeghi MH; Sina S; Alavi M; Giammarile F
Ann Nucl Med; 2023 Dec; 37(12):645-654. PubMed ID: 37768493
[TBL] [Abstract][Full Text] [Related]
19. Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI.
Sharkey AR; Sah BR; Withey SJ; Bhuva S; Neji R; Jeljeli S; Green A; Cook GJR; Goh V;
Eur J Hybrid Imaging; 2021 Dec; 5(1):23. PubMed ID: 34897589
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of ovarian tumors by ultrasonography and X-ray CT].
Watanabe H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2267-73. PubMed ID: 3543168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
